Vivmark Residential (VMRK US)
VMRK US$60.90
20 minute delayed
14 days free access
Join Market Matters and get full access to all our Opinion + Action
Performance
Advanced charting functionality with the ability to amend timeframes, chart type & indicator selection, powered by TradingView.
Share price activity
Displays share price activity. Volume = number of shares traded, Turnover = value of shares traded, VWAP = volume-weighted average price for the day, sourced from Morningstar.
- Last (Price)
- 60.90
- Change
- ▼ -1.65 (-2.64)
- Bid / Ask
- 60.88 - 60.89
- Volume
- 1,333,922
- Turnover
- 75,091,241
- Open
- 61.86
- Day Range
- 60.65 - 61.86
- VWAP
- 60.97
- Prev Close
- 62.55
- Last Trade
- 28/10 4:10pm
Key information
Displays key information on the security, sourced from Morningstar.
- Sector
- Real Estate
- Shares Issued
- 374,944,409
- NTA/Share
- 30.25
- Last Dividend
- 0.70
- Dividend Ex Date
- 5 OCT 2026
- Dividend Pay Date
- 16 OCT 2026
Current (USD) · FY2025
Displays key financial data for the most recent fiscal year, in millions. Note - Per share data is in local currency terms irrespective of reporting currency, and may be different to the stated currency, sourced from Morningstar.
- Revenue
- 3,040.73
- EBITDA
- 2,200.55
- Profit
- 1,049.33
- Earnings Per Share (EPS)
- 2.65
- Dividend Per Share (DPS)
- 2.51
- Yield %
- 4.20
- Market Cap
- 47,123.15
- Price to Earnings Ratio (P/E)
- 23.36
Estimates (USD) · FY2027
Displays consensus analyst’s estimates for key measures for the next fiscal year, sourced from Morningstar.
- Revenue
- 3,303.57
- EBITDA
- 2,006.10
- Profit
- 705.83
- Earnings Per Share (EPS)
- 1.73
- Dividend Per Share (DPS)
- 2.64
Quantitative rating
Displays Morningstar’s Quantitative Equity Research Rating for the security: a star rating from 1 (overvalued) to 5 (undervalued) from the share price against a fair value estimated by a statistical model of Morningstar’s analyst ratings, with the model’s economic moat, financial health and fair value uncertainty, sourced from Morningstar.
Undervalued
- Economic Moat
- None
- Financial Health
- Strong
- Uncertainty
- Medium
Morningstar Quantitative Rating as of 21 OCT 2026.
Quantitative Equity Rating Methodology – view here
Fair value estimate
Displays Morningstar’s quantitative fair value estimate for the security against the current share price, with the band around it: the five-star price below which the model would rate the stock five stars and the one-star price above which it would rate it one star, sourced from Morningstar.
Five-star price 61.44 Fair value 71.23 One-star price 82.59
Morningstar Quantitative Rating as of 21 OCT 2026.
Quantitative valuation
Displays where the share price sits in Morningstar’s quantitative fair value band, from the five-star price (undervalued) to the one-star price (overvalued), with the fair value estimate, the price to fair value ratio, the model’s valuation label and its uncertainty rating, sourced from Morningstar.
Buy
Sell
- Fair Value
- 71.23
- Price / Fair Value
- 0.87
- Valuation
- Undervalued
- Uncertainty
- Medium
Morningstar Quantitative Rating as of 21 OCT 2026. The slider runs from the five-star price (61.44) to the one-star price (82.59).
Displays useful ratios for the security, NB the pricing date used, sourced from Morningstar.
| Ratios |
|---|
| Currency (Price/reporting): USD/USD |
| Exchange Rate: 1.0000 |
Price, volume and trading statistics for the security, sourced from Morningstar.
| Price - closing or last bid | 61.99 |
| Price - 12 month high | 71.50 |
| Price - 12 month low | 57.57 |
| Pricing date | 20 OCT 2026 |
| Volume - avg. trading volume for the last ten days | 4.63 |
| Market capitalization | 47,966.57 |
| 12 Month High price date | 7 JUL 2026 |
| 12 Month Low price date | 20 MAR 2026 |
| Volume - avg. trading volume for the last 3 months | 5.18 |
| Price - 1 Day % Change | 0.16% |
| Price - 13 week price percent change | -9.23% |
| Price - 26 week price percent change | 0.23% |
| Price - 5 Day % Change | 1.96% |
| Price - 52 week price percent change | — |
| Price - YTD price percent change | -2.38% |
| Price % Change Month To Date | 1.03% |
Earnings, dividends, cash flow and book value per share, sourced from Morningstar.
| EPS excluding extraordinary items - most recent fiscal year | 2.649 |
| EPS excluding extraordinary items - trailing 12 month | 2.610 |
| EPS Normalized - most recent fiscal year | 2.037 |
| Revenue/share - most recent fiscal year | 7.623 |
| Revenue/share - trailing 12 month | 7.770 |
| Book value per share - most recent fiscal year | 29.678 |
| Book value per share - most recent quarter | 30.340 |
| Book value (tangible) per share - most recent fiscal year | 30.248 |
| Book value (tangible) per share - most recent quarter | 30.860 |
| Cash per share - most recent fiscal year | 0.479 |
| Cash per share - most recent quarter | 0.204 |
| Cash Flow per share - most recent fiscal year | 4.155 |
| Cash Flow per share - trailing 12 month | 4.130 |
| Dividend per share - most recent fiscal year | 2.506 |
| Dividends per share - trailing 12 month | 2.604 |
| EBITD per share - trailing 12 month | 5.573 |
| EPS Basic excluding extraordinary items - most recent fiscal year | 2.649 |
| EPS Basic excluding extraordinary items - trailing 12 month | 2.607 |
| EPS including extraordinary items - most recent fiscal year | 2.649 |
| EPS including extraordinary items - trailing 12 month | 2.607 |
| Free Cash Flow per share - trailing 12 month | 3.395 |
Valuation multiples such as P/E, price to sales, price to book and enterprise value ratios, sourced from Morningstar.
| P/E excluding extraordinary items, most recent fiscal year | 23.78 |
| P/E Normalized, most recent fiscal year | 30.95 |
| Price to sales - most recent fiscal year | 7.98 |
| Price to Tangible Book - most fiscal year | 2.04 |
| Price to Free Cash Flow per Share - most recent fiscal year | 18.26 |
| Price to Cash Flow per share - trailing 12 month | 15.01 |
| Price to Book - most recent fiscal year | 2.04 |
| P/E excluding extraordinary items high, trailing 12 months | 26.44 |
| P/E excluding extraordinary items low, trailing 12 months | 21.09 |
| Net Debt, LFI | 9,106.54 |
| Net Debt, LFY | 9,306.52 |
| Dividend Yield - 5 Year Average | 3.39% |
| Dividend Yield - indicated annual dividend divided by closing price | 4.21% |
| Current Dividend Yield - Common Stock Primary Issue, LTM | 4.20% |
Cash flow, liquidity and leverage measures, sourced from Morningstar.
| Free Cash Flow - most recent fiscal year | 1,392.44 |
| LT debt/equity - most recent fiscal year | 73.97% |
| Payout ratio - most recent fiscal year | 94.59% |
| Total debt/total equity - most recent fiscal year | 80.22% |
| LT debt/equity - most recent quarter | 67.64% |
| Total debt/total equity - most recent quarter | 75.13% |
| Free Cash Flow - trailing 12 month | 1,346.84 |
| Payout ratio - trailing 12 month | 96.98% |
Key income statement lines for the most recent fiscal year, in millions, sourced from Morningstar.
| Revenue - most recent fiscal year | 3,040.73 |
| Revenue - trailing 12 month | 3,082.70 |
| EBITD - most recent fiscal year | 2,200.55 |
| EBITD - trailing 12 month | 2,210.92 |
| Earnings before taxes - most recent fiscal year | 1,055.46 |
| Earnings before taxes - trailing 12 month | 1,034.62 |
| Net Income available to common - most recent fiscal year | 1,049.33 |
| Net Income available to common - trailing 12 months | 1,025.47 |
| Earnings before taxes Normalized - most recent fiscal year | 746.19 |
| Net Income Available to Common, Normalized - most recent fiscal year | — |
| Earnings per Share, Normalized, Excluding Extraordinary Items, Avg. Diluted Shares Outstanding, TTM | 2.00 |
Profitability margins for the most recent fiscal year, sourced from Morningstar.
| Net Profit Margin % - 1st historical fiscal year | 34.75% |
| Net Profit Margin % - trailing 12 month | 33.59% |
| Operating margin - 1st historical fiscal year | 30.25% |
| Operating margin - trailing 12 month | 29.53% |
| Pretax margin - trailing 12 month | 33.56% |
| Pretax margin - 1st historical fiscal year | 34.71% |
| Operating Margin - 5 year average | 30.14% |
| Pretax Margin - 5 year average | 38.84% |
| Free Operating Cash Flow/Revenue, 5 Year Average | 47.07% |
| Free Operating Cash Flow/Revenue, TTM | 43.69% |
| Net Profit Margin - 5 year average | 38.60% |
Returns on average assets and equity for the fiscal year, the trailing 12 months and as 5 year averages, and net income and revenue per employee in whole currency, sourced from Morningstar.
| Return on average assets - most recent fiscal year | 4.88% |
| Return on average assets - trailing 12 month | 4.69% |
| Return on average equity - most recent fiscal year | 8.90% |
| Return on average equity - trailing 12 month | 8.77% |
| Return on average assets - 5 year average | 5.13% |
| Return on average equity - 5 year average | 9.22% |
| Net Income/employee - most recent fiscal year | 350,912.99 |
| Revenue/employee - most recent fiscal year | 1,009,872.14 |
Growth in revenue, earnings, dividends and book value over recent periods, sourced from Morningstar.
| Revenue growth rate, 5 year | 5.73% |
| EPS growth rate, 5 year | 4.67% |
| Growth rate% - dividend, 3 year | 3.25% |
| Revenue/share (5 yr growth) | 5.37% |
| Growth rate% - Revenue, 3 year | 5.45% |
| Growth rate% - EPS, 3 year | -3.05% |
| Book value per share growth rate, 5 year | 1.47% |
| Capital Spending growth rate, 5 year | 14.09% |
| Earnings Before Interest, Taxes, Depreciation & Amortization, 5 Year CAGR | 4.74% |
Displays analyst’s forecasts for key measures. The estimates can be expanded to see the spread of the calls. Full lines = reported, and dotted lines are forward estimates. Click a measure to add or remove it from the chart, sourced from Morningstar.
Financial forecast (USD, millions except per share)
| Actuals | Estimates | |||||||
| 2025 | 2026 | 2027 | 2028 | 2029 | ||||
| Estimate breakdown | ||||||||
Financial metrics can be plotted on the graph to see trends. Multiple metrics from multiple statements can be plotted against each other, sourced from Morningstar.
Financials (USD, millions)
| Period end: | DEC 21 | DEC 22 | DEC 23 | DEC 24 | DEC 25 |
| Fiscal year: | 2021 | 2022 | 2023 | 2024 | 2025 |
| Period length: | 12 months | 12 months | 12 months | 12 months | 12 months |
Displays all company announcements released by the company to the exchange, sourced from Morningstar.
Announcements
Announcements are available for ASX-listed companies only.
Opinion
No opinions for this company yet.
Action
No actions for this company yet.
Business Summary
Vivmark owns a high-quality apartment portfolio with around 184,000 units and is developing another $4.4 billion of residential properties. The company focuses on owning large, high-quality properties in major metropolitan areas of New England, New York/New Jersey, Washington, D.C., California, and the Pacific Northwest.
Relevant suggested news and content from the site
Video
WATCH
Webinar Recording: Are commodities entering a Supercycle?
Recorded Wednesday 24th June @ 12.30pm
Podcast
LISTEN
Thursday 11th September – Dow off -220pts, SPI off -20pts
Daily Podcast Direct from the Desk
Video
WATCH
Buy Hold Sell: The 6 income stocks readers love, plus 2 expert ideas
Recorded 10th June 2026
Podcast
LISTEN
Wednesday 10th September – Dow up +196pts, SPI down -4pts
Daily Podcast Direct from the Desk
